Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
Abstract
BACKGROUND: The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS: Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS: A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS: The novel coronavirus might have a role in causing SARS.
Overview
CoChat Summary
## TL;DR
The paper identifies a previously unknown coronavirus in patients with severe acute respiratory syndrome (SARS) and provides PCR and serologic evidence linking it to the illness. It also reports that viral RNA was found at very high levels in sputum, with lower-level detection in plasma and later in stool, supporting a respiratory infection with possible additional shedding routes.
## Key findings
- A novel coronavirus was isolated from sputum of the index patient after 6 days of incubation in Vero-cell culture, and a 300-nucleotide sequence was obtained by random RT-PCR.
- Genetic analysis found the virus was only distantly related to known coronaviruses, with the BNI-1 sequence differing by 39% to 46% from known sequences and by 50% to 60% identical nucleotide sequence to known coronaviruses.
- In the Hanoi outbreak panel, the virus was detected in 100% of patients with probable SARS, 23% of those with suspected SARS, and 0% of healthy contacts.
- Quantitative PCR found viral RNA concentrations of up to 100 million molecules per milliliter in sputum; the index patient also had RNA in plasma at 190 (day 9) and stool on day 25, and Contact 1 had 6.3 × 10^4 in sputum and 4.1 × 10^5 in BAL.
## Methods
- Clinical specimens from SARS patients were screened for known and unknown pathogens using cell culture, electron microscopy, PCR, antigen ELISA, serology, and sequence/phylogenetic analysis.
- The study examined specimens from 3 patients in Frankfurt (index patient, Contact 1, Contact 2) and a panel of 49 specimens from 18 suspected/probable SARS patients and 21 healthy contacts in Hanoi, plus 54 stool controls from Germany.
- A random RT-PCR approach and subsequent nested and real-time RT-PCR assays were developed to identify and quantify the novel virus, with specificity tested against several other coronaviruses.
## Limitations
- The paper itself states that larger studies with appropriate control groups are needed to verify or reject the hypothesis that this virus causes SARS.
- The authors note that the antibody response might not be definitively directed against the novel coronavirus, because the antigen used in serology came from primary cultures; they say this should be tested with plaque-purified virus or recombinant proteins.
- Evidence of causation is not established here; the paper shows association and detection in patients, but the conclusion is only that the virus “might have a role” in causing SARS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 7 Not checked · 67 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The presence of viral RNA in stool of the patients late during convalescence is reminiscent of characteristics of other coronaviruses. 13”
What the sources say
- Partly supportedcites [13] matched to “Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle” (2001) sourceExperimental — accuracy not yet measured
Our copy of Cho et al (2001) supports only the general point that a bovine coronavirus is present/shed in feces: fecal samples from 56 feedlot steers were positive for BCV by antigen-capture ELISA and virus isolation (Results, p. 1; Materials and Methods, Sample Collections), and the Discussion (p. 6) notes 22% of fecal samples from cattle without diarrhea were antigen-positive, suggesting they 'had diarrhea during shipping or at the auction barn and were still shedding BCV'. The specific elements the citing sentence attributes are absent: detection was of antigen/infectious virus, not viral RNA (no RT-PCR assay appears anywhere in our copy; RT-PCR of feces belongs to a work it cites, Tsunemitsu and Saif, ref 35), samples were taken only on days 0, 4, 14 and 21 after arrival rather than late during convalescence, in cattle rather than human patients, and the paper makes no comparative statement about shared characteristics of other coronaviruses. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Infected patients showed seroconversion on the Vero cells in which the virus was isolated.”
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About 20 distinct DNA fragments were obtained and sequenced.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three of the fragments did not match any nucleotide sequence in the data base.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“since there was serologic evidence of an acute infection with this virus in our index patient and also in Contact 1”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 75 claims and to verify the 7 references still open.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 11
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768
Drosten, C., Göttig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., & Günther, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2323-2330.2002 · Cited by 631
Self-citationImported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000504 · Cited by 200
Self-citationStephensen, C. B., Casebolt, D. B., & Gangopadhyay, N. N. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00017-9 · Cited by 135
Cho, K.-O., Hoet, A. E., Loerch, S. C., Wittum, T. E., & Saif, L. J. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1436 · Cited by 88
TTV a common virus, but pathogenic?
Cossart, Y. E. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77802-8 · Cited by 44
HGV: hepatitis G virus or harmless G virus?
Kew, M. C., & Kassianides, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98020-4 · Cited by 39
Research works printed but not linked: 2
- 2003, Wkly Epidemiol Rec, 78, 81
- 2003, Wkly Epidemiol Rec, 78, 73
Cited by
Items 701–800 of 1,020
Rainer, T. H., Cameron, P. A., Smit, D., Ong, K. L., Hung, A. N. W., Nin, D. C. P., Ahuja, A. T., Si, L. C. Y., & Sung, J. J. Y. (2003) · BMJ · doi:10.1136/bmj.326.7403.1354 · Cited by 146
Retroviral Vectors Pseudotyped with Severe Acute Respiratory Syndrome Coronavirus S Protein
Giroglou, T., Cinatl, J., Rabenau, H., Drosten, C., Schwalbe, H., Doerr, H. W., & von Laer, D. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9007-9015.2004 · Cited by 140
Self-citationWang, S., Guo, F., Liu, K., Wang, H., Rao, S., Yang, P., & Jiang, C. (2008) · Virus Research · doi:10.1016/j.virusres.2008.03.004 · Cited by 135
The emergence of the Middle East Respiratory Syndrome coronavirus
Milne-Price, S., Miazgowicz, K. L., & Munster, V. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12166 · Cited by 152
Ghosh, A. K., Takayama, J., Aubin, Y., Ratia, K., Chaudhuri, R., Baez, Y., Sleeman, K., Coughlin, M., Nichols, D. B., Mulhearn, D. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900611t · Cited by 129
Yao, H., Zhang, N., Zhang, R., Duan, M., Xie, T., Pan, J., Peng, E., Huang, J., Zhang, Y., Xu, X., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00683 · Cited by 132
Sampling and detection of corona viruses in air: A mini review
Rahmani, A., Leili, M., Azarian, G., & Poormohammadi, A. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140207 · Cited by 134
Reappearance of effector T cells is associated with recovery from COVID-19
Odak, I., Barros‐Martins, J., Bošnjak, B., Stahl, K., David, S., Wiesner, O., Busch, M., Hoeper, M. M., Pink, I., Welte, T., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102885 · Cited by 143
Baumgarte, S., de Souza Luna, L. K., Grywna, K., Panning, M., Drexler, J. F., Karsten, C., Huppertz, H. I., & Drosten, C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01468-07 · Cited by 136
Self-citationCoronavirus Gene 7 Counteracts Host Defenses and Modulates Virus Virulence
Cruz, J. L. G., Sola, I., Bécares, M., Alberca, B., Plana, J., Enjuanes, L., & Zúñiga, S. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002090 · Cited by 143
In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2
Milanetti, E., Miotto, M., Rienzo, L. D., Nagaraj, M., Monti, M., Golbek, T. W., Gosti, G., Roeters, S. J., Weidner, T., Otzen, D. E., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.690655 · Cited by 142
de Groot-Mijnes, J. D. F., van Dun, J. M., der Most, R. G. V., & de Groot, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.1036-1044.2005 · Cited by 133
Risk Factors for Severity in Children with Coronavirus Disease 2019
Tsabouri, S., Makis, A., Kosmeri, C., & Siomou, E. (2021) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.07.014 · Cited by 132
“The first serious CoV disease outbreak occurred in China in 2002, when the novel SARS-CoV emerged, which was thought to have been transmitted from civet cats or bats to humans.(3,4) The second novel CoV emerged in Saudi Arabia in 2012, the Middle East respiratory syndrome”
Petit, C. M., Chouljenko, V. N., Iyer, A., Colgrove, R., Farzan, M., Knipe, D. M., & Kousoulas, K. G. (2007) · Virology · doi:10.1016/j.virol.2006.10.034 · Cited by 135
Coronaviridae and SARS-associated Coronavirus Strain HSR1
Vicenzi, E., Canducci, F., Pinna, D., Mancini, N., Carletti, S., Lazzarin, A., Bordignon, C., Poli, G., & Clementi, M. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1003.030683 · Cited by 132
Fukushi, S., Mizutani, T., Saijo, M., Matsuyama, S., Miyajima, N., Taguchi, F., Itamura, S., Kurane, I., & Morikawa, S. (2005) · Journal of General Virology · doi:10.1099/vir.0.80955-0 · Cited by 139
Vijgen, L., Keyaerts, E., Moës, E., Maes, P., Duson, G., & Ranst, M. A. V. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5452-5456.2005 · Cited by 134
Chen, Y. A., Liang, S., Shih, Y.-P., Chen, C., Lee, Y.-M., Chang, L., Jung, S.-Y., Ho, M.-S., Liang, K., Chen, H., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.359-365.2006 · Cited by 141
Yang, Y., Ye, F., Zhu, N., Wang, W., Deng, Y., Zhao, Z., & Tan, W. (2015) · Scientific Reports · doi:10.1038/srep17554 · Cited by 132
Müller, C., Hardt, M., Schwudke, D., Neuman, B. W., Pleschka, S., & Ziebuhr, J. (2017) · Journal of Virology · doi:10.1128/jvi.01463-17 · Cited by 136
Giordani, S., Marassi, V., Zattoni, A., Roda, B., & Reschiglian, P. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115751 · Cited by 141
Pogrebnyak, N., Golovkin, M., Andrianov, V. M., Spitsin, S. V., Smirnov, Y., Egolf, R., & Koprowski, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503760102 · Cited by 132
Luo, H., Chen, Q., Chen, J., Chen, K., Shen, X., & Jiang, H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.080 · Cited by 135
Wu, C., King, K., Kuo, C., Fang, J., Wu, Y., Ho, M., Liao, C.-L., Shie, J., Liang, P., & Wong, C. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.12.008 · Cited by 131
Metagenomics for the Discovery of Novel Human Viruses
Tang, P., & Chiu, C. Y. (2010) · Future Microbiology · doi:10.2217/fmb.09.120 · Cited by 147
Multi-level inhibition of coronavirus replication by chemical ER stress
Shaban, M. S., Müller, C., Mayr‐Buro, C., Weiser, H., Meier‐Soelch, J., Albert, B. V., Weber, A., Linne, U., Hain, T., Babayev, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25551-1 · Cited by 140
Self-citationCheng, C., & Cheung, M. W. L. (2005) · Journal of Personality · doi:10.1111/j.1467-6494.2004.00310.x · Cited by 130
Iwata-Yoshikawa, N., Uda, A., Suzuki, T., Tsunetsugu-Yokota, Y., Sato, Y., Morikawa, S., Tashiro, M., Sata, T., Hasegawa, H., & Nagata, N. (2014) · Journal of Virology · doi:10.1128/jvi.00983-14 · Cited by 135
Cabeça, T. K., Granato, C., & Bellei, N. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12101 · Cited by 133
Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells
Spiegel, M., Schneider, K., Weber, F., Weidmann, M., & Hufert, F. T. (2006) · Journal of General Virology · doi:10.1099/vir.0.81624-0 · Cited by 128
Viral detection by electron microscopy: past, present and future
Roingeard, P. (2008) · Biology of the Cell · doi:10.1042/bc20070173 · Cited by 155
Gehrke, C., Steinmann, J., & Goroncy‐Bermes, P. (2003) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.08.019 · Cited by 148
TELEMAN, M. D., BOUDVILLE, I. C., HENG, B. H., ZHU, D., & LEO, Y. S. (2004) · Epidemiology and Infection · doi:10.1017/s0950268804002766 · Cited by 130
He, Y., Zhou, Y., Siddiqui, P., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.052 · Cited by 130
The life cycle of SARS coronavirus in Vero E6 cells
Qinfen, Z., Cui, J., Huang, X., Huanying, Z., Jicheng, H., Fang, L., Li, K., & Jingqiang, Z. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20095 · Cited by 131
Only One Protomer Is Active in the Dimer of SARS 3C-like Proteinase
Chen, H., Wei, P., Huang, C., Tan, L., Liu, Y., & Lai, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510745200 · Cited by 129
Gong, Y.-N., Tsao, K.-C., Hsiao, M.-J., Huang, C.-G., Huang, P.-N., Huang, P.-W., Lee, K.-M., Liu, Y.-C., Yang, S.-L., Kuo, R.-L., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1782271 · Cited by 131
RespiFinder: a New Multiparameter Test To Differentially Identify Fifteen Respiratory Viruses
Reijans, M., Dingemans, G., Klaassen, C. H. W., Meis, J. F. G. M., Keijdener, J., Mulders, B., Eadie, K., van Leeuwen, W., van Belkum, A., Horrevorts, A. M., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02294-07 · Cited by 137
Che, X.-Y., Qiu, L., Pan, Y.-X., Wen, K., Hao, W., Zhang, L.-Y., Wang, Y.-D., Liao, Z.-Y., Xu, H., Cheng, V. C., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2629-2635.2004 · Cited by 139
He, R., Leeson, A., Ballantine, M., Andonov, A. P., Baker, L. A., Dobie, F. A., Li, Y., Bastien, N., Feldmann, H., Strocher, U., et al. (2004) · Virus Research · doi:10.1016/j.virusres.2004.05.002 · Cited by 128
SARS–associated Coronavirus Replication in Cell Lines
Kaye, M., Druce, J. D., Tran, T., Kostecki, R., Chibo, D., Morris, J. L., Catton, M. G., & Birch, C. J. (2006) · Emerging infectious diseases · doi:10.3201/eid1201.050496 · Cited by 128
Hashem, A. M., Alghamdi, B. S. A., Algaissi, A. A., Alshehri, F. S., Bukhari, A. I., Alfaleh, M. A., & Memish, Z. A. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101735 · Cited by 131
Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance
Peterson, L. R. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01238.x · Cited by 127
Severe Acute Respiratory Syndrome Coronavirus 3a Protein Is a Viral Structural Protein
Ito, N., Mossel, E. C., Narayanan, K., Popov, V. L., Huang, C., Inoue, T., Peters, C. J., & Makino, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.3182-3186.2005 · Cited by 128
Báez-Santos, Y. M., Mielech, A. M., Deng, X., Baker, S., & Mesecar, A. D. (2014) · Journal of Virology · doi:10.1128/jvi.01294-14 · Cited by 128
Treatment of severe acute respiratory syndrome
Lai, S. T. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0004-z · Cited by 140
Anand, K. B., Karade, S. K., Sen, S., & Gupta, R. M. (2020) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2020.04.008 · Cited by 150
Emerging waterborne pathogens: can we kill them all?
Nwachuku, N., & Gerba, C. P. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.04.010 · Cited by 153
Huang, Y., Yang, Z.-Y., Kong, W.-P., & Nabel, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12557-12565.2004 · Cited by 130
Wong, C. W., Albert, T. J., Vega, V. B., Norton, J. E., Cutler, D. J., Richmond, T., Stanton, L. W., Liu, E. T., & Miller, L. D. (2004) · Genome Research · doi:10.1101/gr.2141004 · Cited by 127
Takeda, M., Chang, C., Ikeya, T., Güntert, P., Chang, Y.-H., Hsu, Y.-L., Huang, T.-H., & Kainosho, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.093 · Cited by 126
Altenburg, A. F., Kreijtz, J. H. C. M., de Vries, R. D., Song, F., Fux, R., Rimmelzwaan, G. F., Sutter, G., & Volz, A. (2014) · Viruses · doi:10.3390/v6072735 · Cited by 150
Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Tsoi, H.-W., Fung, A. M. Y., Kao, R. Y. T., Chan, K., Peiris, M. J. S., & Yuen, K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3054-3058.2005 · Cited by 131
Poon, L. L. M., Chan, K. H., Wong, O. K., Cheung, T., Ng, I. H. Y., Zheng, B., Seto, W., Yuen, K., Guan, Y., & Peiris, M. J. S. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.023663 · Cited by 129
Detection of SARS Coronavirus in Plasma by Real-Time RT-PCR
Grant, P. R., Garson, J. A., Tedder, R. S., Chan, P. K. S., Tam, J. S., & Sung, J. J. Y. (2003) · New England Journal of Medicine · doi:10.1056/nejm200312183492522 · Cited by 129
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light
Ragan, I. K., Hartson, L., Pidcoke, H. F., Bowen, R., & Goodrich, R. P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233947 · Cited by 133
Severe acute respiratory syndrome (SARS)—paradigm of an emerging viral infection
Berger, A., Drosten, C., Doerr, H. W., Stürmer, M., & Preiser, W. (2003) · Journal of Clinical Virology · doi:10.1016/j.jcv.2003.09.011 · Cited by 141
Self-citationRapid Diagnosis of a Coronavirus Associated with Severe Acute Respiratory Syndrome (SARS)
Poon, L. L. M., Wong, O. K., Luk, W., Yuen, K. Y., Peiris, J. S. M., & Guan, Y. (2003) · Clinical Chemistry · doi:10.1373/49.6.953 · Cited by 127
The Occupational and Psychosocial Impact of SARS on Academic Physicians in Three Affected Hospitals
Grace, S. L., Hershenfield, K., Robertson, E., & Stewart, D. E. (2005) · Psychosomatics · doi:10.1176/appi.psy.46.5.385 · Cited by 125
Sheahan, T., Rockx, B., Donaldson, E., Sims, A., Pickles, R., Corti, D., & Baric, R. (2008) · Journal of Virology · doi:10.1128/jvi.02041-07 · Cited by 127
Yeh, S.-H., Wang, H.-Y., Tsai, C.-Y., Kao, C.-L., Yang, J.-Y., Liu, H.-W., Su, I.-J., Tsai, S.-F., Chen, D.-S., Chen, P.-J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307904100 · Cited by 127
Zhou, W., Wang, W., Wang, H., Lu, R., & Tan, W. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-433 · Cited by 124
“The SARS epidemic that originated from southern China in 2003 sparked interest in all areas of coronavirus research [4-9].”
BackgroundEmerging respiratory agents: New viruses for old diseases?
Sloots, T. P., Whiley, D. M., Lambert, S. B., & Nissen, M. D. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.03.002 · Cited by 124
Raghuwanshi, D., Mishra, V., Das, D., Kaur, K., & Suresh, M. R. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200553x · Cited by 126
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
Xia, S., Liu, Q., Wang, Q., Sun, Z., Su, S., Du, L., Ying, T., Lu, L., & Jiang, S. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.007 · Cited by 125
RNAi, a new therapeutic strategy against viral infection
TAN, F. L., & Yin, J. Q. (2004) · Cell Research · doi:10.1038/sj.cr.7290248 · Cited by 139
Kwek, S.-K., Chew, W.-M., Ong, K.-C., Ng, A. W.-K., Lee, L. S.-U., Kaw, G., & Leow, M. K.-S. (2006) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2005.08.020 · Cited by 124
Scheuplein, V. A., Seifried, J., Malczyk, A. H., Miller, L., Höcker, L., Vergara-Alert, J., Dolnik, O., Zielecki, F., Becker, B., Spreitzer, I., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03607-14 · Cited by 123
Self-citationRoh, C., & Jo, S. (2011) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.2721 · Cited by 123
Oostra, M., de Haan, C. A. M., de Groot, R. J., & Rottier, P. J. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2326-2336.2006 · Cited by 125
Recently Discovered Human Coronaviruses
Wevers, B. A., & van der Hoek, L. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.07.007 · Cited by 143
Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Tsoi, H.-W., Fung, A. M. Y., Chan, K., Tam, V. K. P., Peiris, M. J. S., & Yuen, K. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2306-2309.2004 · Cited by 130
Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states
Gür, M., Taka, E., Yilmaz, S. Z., Kılınç, C., Aktas, U., & Gölcük, M. (2020) · The Journal of Chemical Physics · doi:10.1063/5.0011141 · Cited by 134
Pathophysiology and treatment strategies for COVID-19
Kumar, M., & Khodor, S. A. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02520-8 · Cited by 123
Raaben, M., Groot Koerkamp, M. J. A., Rottier, P. J. M., & de Haan, C. A. M. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00951.x · Cited by 125
de Lang, A., Osterhaus, A. D. M. E., & Haagmans, B. L. (2006) · Virology · doi:10.1016/j.virol.2006.06.011 · Cited by 124
Self-citationSimmons, G., Bertram, S., Glowacka, I., Steffen, I., Chaipan, C., Agudelo, J., Lu, K., Rennekamp, A. J., Hofmann, H., Bates, P., et al. (2011) · Virology · doi:10.1016/j.virol.2011.02.020 · Cited by 122
Update on Human Rhinovirus and Coronavirus Infections
Greenberg, S. (2016) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0036-1584797 · Cited by 124
Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures
Zhao, S., Ling, K., Yan, H., Zhong, L., Peng, X., Yao, S., Huang, J., & Chen, X. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.02.039 · Cited by 123
COVID-19: Are Africa’s diagnostic challenges blunting response effectiveness?
Kobia, F., & Gitaka, J. (2020) · AAS Open Research · doi:10.12688/aasopenres.13061.1 · Cited by 132
Xavier-Santos, D., Padilha, M., Fabiano, G. A., Vinderola, G., da Cruz, A. G., Sivieri, K., & Antunes, A. E. C. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.12.033 · Cited by 128
Tseng, C.-T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P. C., Garron, T., Atmar, R. L., Peters, C. J., & Couch, R. B. (2012) · PLoS ONE · doi:10.1371/annotation/2965cfae-b77d-4014-8b7b-236e01a35492 · Cited by 122
Anti-SARS coronavirus agents: a patent review (2008 – present)
Kumar, V., Jung, Y., & Liang, P. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.823159 · Cited by 127
Spruth, M., Kistner, O., Savidis-Dacho, H., Hitter, E., Crowe, B., Gerencer, M., Brühl, P., Grillberger, L., Reiter, M., Tauer, C., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.055 · Cited by 119
Keil, S. D., Bowen, R. A., & Marschner, S. (2016) · Transfusion · doi:10.1111/trf.13860 · Cited by 121
Carcaterra, M., & Caruso, C. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110412 · Cited by 133
Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein
He, R., Leeson, A., Andonov, A., Li, Y., Bastien, N., Cao, J., Osiowy, C., Dobie, F., Cutts, T., Ballantine, M., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.075 · Cited by 124
Raaben, M., Posthuma, C. C., Verheije, M. H., Lintelo, E. G. T., Kikkert, M., Drijfhout, J. W., Snijder, E. J., Rottier, P. J. M., & de Haan, C. A. M. (2010) · Journal of Virology · doi:10.1128/jvi.00485-10 · Cited by 128
Severe Acute Respiratory Syndrome in Children
Stockman, L. J., Massoudi, M. S., Helfand, R. F., Erdman, D. D., Siwek, A. M., Anderson, L. J., & Parashar, U. D. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000247136.28950.41 · Cited by 123
Safe tracheostomy for patients with severe acute respiratory syndrome
Wei, W., Tuen, H. H., Ng, R. W. M., & Lam, L. K. (2003) · The Laryngoscope · doi:10.1097/00005537-200310000-00022 · Cited by 123
Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19
Refaat, H., Mady, F. M., Sarhan, H. A., Rateb, H. S., & Alaaeldin, E. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120028 · Cited by 122
G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells
Yuan, X., Shan, Y., Zhao, Z., Chen, J., & Cong, Y. (2005) · Virology Journal · doi:10.1186/1743-422x-2-66 · Cited by 119
Li, B., Si, H.-R., Zhu, Y., Yang, X., Anderson, D. E., Shi, Z., Wang, L., & Zhou, P. (2020) · mSphere · doi:10.1128/msphere.00807-19 · Cited by 119
Pachetti, M., Marini, B., Giudici, F., Benedetti, F., Angeletti, S., Ciccozzi, M., Masciovecchio, C., Ippodrino, R., & Zella, D. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02501-x · Cited by 120
He, Y., Li, J., Li, W., Lustigman, S., Farzan, M., & Jiang, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6085 · Cited by 117
Eickmann, M., Gravemann, U., Handke, W., Tolksdorf, F., Reichenberg, S., Müller, T. H., & Seltsam, A. W. (2018) · Transfusion · doi:10.1111/trf.14652 · Cited by 121
Self-citationMiknis, Z. J., Donaldson, E. F., Umland, T. C., Rimmer, R. A., Baric, R. S., & Schultz, L. W. (2009) · Journal of Virology · doi:10.1128/jvi.01505-08 · Cited by 118
A Bat-Derived Putative Cross-Family Recombinant Coronavirus with a Reovirus Gene
Huang, C., Liu, W. J., Xu, W. H., Jin, T., Zhao, Y., Song, J., Shi, Y., Ji, W., Jia, H., Zhou, Y., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005883 · Cited by 128
Nakagawa, K., Narayanan, K., Wada, M., & Makino, S. (2018) · Journal of Virology · doi:10.1128/jvi.00902-18 · Cited by 120
Moreira, R. D. S. (2020) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00080020 · Cited by 222
Metadata
- Authors
- Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A.-M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Müller, S., Rickerts, V., Stürmer, M., Vieth, S., Klenk, H.-D., Osterhaus, A. D. M. E., Schmitz, H., & Doerr, H. W.
- Affiliations
- Goethe University Frankfurt (DE)
- From the Bernhard Nocht Institute for Tropical Medicine, National Reference Center for Tropical Infectious Diseases, Hamburg (C.D., S.G., M.P., K.G., S.K., S.M., S.V., H.S.); the Institute of Medical Virology (W.P., H.R., A.B., J.C., M.S., H.W.D.) and the Medical Clinic III (H.-R.B., V.R.), Johann Wolfgang Goethe University, Frankfurt am Main; and the Institute of Virology, Philipps University, Marburg (S.B., L.K., M.E., H.-D.K.) — all in Germany; the Pasteur Institute, Molecular Genetics of Respiratory...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-15
- Volume
- 348
- Issue
- 20
- Pages
- 1967-1976
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132260239
- Semantic Scholar
- 79116f5bb552a1a23de85d03899ab0b3763c81ee
- Cited by
- 4,574
- References
- 10
- Citations by year
- 2026: 40 · 2025: 91 · 2024: 141 · 2023: 193 · 2022: 361 · 2021: 646 · 2020: 913 · 2019: 50 · 2018: 45 · 2017: 49 · 2016: 60 · 2015: 65 · 2014: 91 · 2013: 83 · 2012: 93
- FWCI
- 222.93
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, novel coronavirus, SARS-CoV, virus identification, viral RNA detection, seroconversion, fecal viral shedding, plasma viral RNA
- MeSH terms
- Adult, Amino Acid Sequence, Animals, Base Sequence, Cattle, Disease Outbreaks, DNA, Viral, Female, Humans, Male, Molecular Sequence Data, Phylogeny, RNA, Viral, Sequence Homology, Nucleic Acid, Sputum, Polymerase Chain Reaction, Coronavirus, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.